Mizuho Securities Downgrades Amedisys Inc to Neutral

Brokerage firm Mizuho Securities Downgrades its rating on Amedisys Inc(NASDAQ:AMED). The shares have been rated Neutral. Previously, the analysts had a Buy rating on the shares. The rating by Mizuho Securities was issued on Aug 3, 2016.

In a different note, Stephens & Co. said it Initiates Coverage on Amedisys Inc, according to a research note issued on Jun 17, 2016. The shares have been rated ‘Equal-weight’ by the firm.

Amedisys Inc (AMED) shares turned negative on Fridays trading session with the shares closing down -0.19 points or -0.39% at a volume of 2,17,654. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $48.99. The peak price level was also seen at $48.99 while the days lowest was $48.22. Finally the shares closed at $48.6. The 52-week high of the shares is $55.16 while the 52-week low is $31.16. According to the latest information available, the market cap of the company is $1,630 M.

Amedisys Inc(AMED) last announced its earnings results on Aug 2, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $361.69M. Analysts had an estimated revenue of $352.53M. Earnings per share were $0.42. Analysts had estimated an EPS of $0.42.

Several Insider Transactions has been reported to the SEC. On May 17, 2016, Bruce D Perkins (director) purchased 1,000 shares at $50.21 per share price.Also, On May 13, 2016, Scott G Ginn (officer ) sold 6,000 shares at $51.65 per share price.On Aug 19, 2015, Donald A Washburn (director) sold 20,000 shares at $45.51 per share price, according to the Form-4 filing with the securities and exchange commission.

Amedisys Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360000 patients each year. The Company has care network across 34 states. As of December 31 2014 it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Company’s home health segment delivers a range of services in the homes of individuals who may be recovering from surgery have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Amedisys Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amedisys Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.